The term “chronic kidney disease” (CKD) gained widespread adoption in medical practice during the 1990s, coinciding with clinical trials that demonstrated angiotensin-converting enzyme (ACE) inhibitors could significantly slow the progression of kidney damage, irrespective of the cause. Here, ACE is linked to chronic kidney disease.